LOXL1 and neoplasm: So far, the tumor-suppressive role of LOXL1-AS1 has not been confirmed in cancer cell lines or cancer tissues, whereas all studies conducted to date have indicated its oncogenic role; thus, LOXL1-AS1 may prove valuable as a diagnostic biomarker or therapeutic target.